Imaging of Mediastinal Lymph Nodes: CT, MR, and FDG PET

Radiographics

Volumn 18, Issue 5, 1998, Pages 1061-1069

  Boiselle, Phillip M ^a   Patz Jr , Edward F ^b   Vining, David J ^c   Weissleder, Ralph ^d   Shepard, Jo Anne O ^d   McLoud, Theresa C ^d  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b DUKE UNIVERSITY HOSPITAL   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Lung neoplasms, metastases, 67.3235, 67.337; Lung neoplasms, staging, 67.3235, 67.337; Lymphatic system, neoplasms, 998.33; Mediastinum, neoplasms, 67.337

Indexed keywords

DIAGNOSTIC AGENT; FLUORINE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; MEDIASTINUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY; REVIEW; SCINTISCANNING;

CARCINOMA, NON-SMALL-CELL LUNG; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MEDIASTINUM; NEOPLASM STAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032161045     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiographics.18.5.9747607     Document Type: Article

References (17)

1. Jett J, Feins R, Kvale P, et al. Pretreatment evaluation of non-small-cell lung cancer: official statement of the American Thoracic Society and the European Respiratory Society. Am J Respir Crit Care Med 1997; 156:320-332.
2. McLoud TC, Bourgoin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182:319-323.
3. Staples CA, Müller NL, Miller RR, Evans KG, Nelems B. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. Radiology 1988; 167:367-372.
4. Webb WR, Gatsonis C, Zerhouni EA. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178:705-713.
5. Quint LE, Francis IR, Wahl RL, et al. Preoperative staging of non-small cell carcinoma of the lung: imaging methods. AJR 1995; 164:1349-1359.
6. Steinert HC, Hauser M, Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202: 441-446.
7. Wahl RL, Quint LE, Greenough RL, et al. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191:371-377.
8. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Chest 1997; 112: 1480-1486:
9. Protopapas A, Westcott JL. Transthoracic needle biopsy of mediastinal lymph nodes for staging lung and other cancers. Radiology 1997; 199:489-496.
10. Vining DJ, Liu K, Choplin RH, Haaponik EF. Virtual bronchoscopy: relationships of virtual reality endobronchial simulations to actual bronchoscopic findings. Chest 1996; 109:549-553.
11. Martini N, Heelan R, Westcott J, et al. Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma. J Thorac Cardiovasc Surg 1985; 90:639-648.
12. Weissleder R, Elizondo G, Wittenberg J, et al. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990; 175: 494-498.
13. Weissleder R, Cheng H, Bogdanova A, Bogdanov A. Magnetically labeled cells can be detected by MR imaging. JMRI 1997; 7:258-263.
14. Vassallo P, Matei C, Heston WDW, et al. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 1994; 193:501-506.
15. Patz EF, Goodman PC. Positron emission tomography imaging of the thorax. Radiol Clin North Am 1994; 32:811-823.
16. Patz EF, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188:487-490.
17. Gambhir SS, Hoh CK, Phelps ME, Madar I, Maddahi J. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J Nucl Med 1996; 37:1428-1436.